Personalized Therapy and Clinical Outcome for Retinal Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 25 April 2026 | Viewed by 28
Special Issue Editor
Interests: retinal diseases; vitreoretinal diseases; vitrectomy; vitreoretinal surgery; diabetic retinopathy; retinal vein occlusion
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the growing significance of personalized therapy in the management of retinal diseases—a crucial area in modern clinical ophthalmology. Retinal diseases such as diabetic retinopathy, age-related macular degeneration, and inherited retinal disorders exhibit diverse pathophysiological mechanisms, requiring individualized treatment approaches.
This Special Issue will highlight emerging trends in precision medicine, advances in retinal imaging, biomarker-driven therapies, and artificial intelligence-supported clinical decision-making. It will also explore the integration of genetic, molecular, and clinical data to enhance diagnostic accuracy and therapeutic outcomes.
We aim to provide a platform for sharing original research and clinical trials that contribute to personalized retinal care. We encourage contributions from clinicians and researchers alike to broaden the discussion and accelerate innovation in this field.
This Special Issue aims to support the advancement of personalized ophthalmic care and improve the quality of life of patients with retinal diseases.
Prof. Dr. Takeshi Iwase
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal diseases
- retinal imaging
- clinical outcomes
- artificial intelligence
- biomarkers
- optical coherence tomography (OCT)
- vitrectomy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
